These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11170687

  • 1. Three new hyperforin analogues from Hypericum perforatum.
    Shan MD, Hu LH, Chen ZL.
    J Nat Prod; 2001 Jan; 64(1):127-30. PubMed ID: 11170687
    [Abstract] [Full Text] [Related]

  • 2. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L, Appendino G, Jakupovic J, Bombardelli E.
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [Abstract] [Full Text] [Related]

  • 3. [Chemical constituents of Hypericum perforatum].
    Shi MJ, Hu JW, Wang JJ, Zhen B, Wang X, Ji TF.
    Zhongguo Zhong Yao Za Zhi; 2018 Jul; 43(13):2726-2731. PubMed ID: 30111023
    [Abstract] [Full Text] [Related]

  • 4. Further degradation product of hyperforin from Hypericum perforatum (St John's Wort).
    Vajs V, Vugdelija S, Trifunović S, Karadzić I, Juranić N, Macura S, Milosavljević S.
    Fitoterapia; 2003 Jul; 74(5):439-44. PubMed ID: 12837358
    [Abstract] [Full Text] [Related]

  • 5. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
    Fourneron JD, Naït-Si Y.
    Phytochem Anal; 2006 Jul; 17(2):71-7. PubMed ID: 16634282
    [Abstract] [Full Text] [Related]

  • 6. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
    Charchoglyan A, Abrahamyan A, Fujii I, Boubakir Z, Gulder TA, Kutchan TM, Vardapetyan H, Bringmann G, Ebizuka Y, Beerhues L.
    Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
    [Abstract] [Full Text] [Related]

  • 7. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 8. Three new phloroglucinol derivatives from Hypericum scabrum.
    Ma J, Ji TF, Yang JB, Wang AG, Su YL.
    J Asian Nat Prod Res; 2012 Apr; 14(5):508-14. PubMed ID: 22530678
    [Abstract] [Full Text] [Related]

  • 9. Oxidation products of hyperforin from Hypericum perforatum.
    Trifunović S, Vajs V, Macura S, Juranić N, Djarmati Z, Jankov R, Milosavljević S.
    Phytochemistry; 1998 Nov; 49(5):1305-10. PubMed ID: 9842729
    [Abstract] [Full Text] [Related]

  • 10. Hyperforin.
    Beerhues L.
    Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
    [Abstract] [Full Text] [Related]

  • 11. Measurement of hyperforin a constituent of St. John's wort in plasma by high-performance liquid chromatography.
    Chi JD, Franklin M.
    J Chromatogr B Biomed Sci Appl; 1999 Dec 10; 735(2):285-8. PubMed ID: 10670742
    [Abstract] [Full Text] [Related]

  • 12. Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L.
    Erdelmeier CA.
    Pharmacopsychiatry; 1998 Jun 10; 31 Suppl 1():2-6. PubMed ID: 9684941
    [Abstract] [Full Text] [Related]

  • 13. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
    Vormfelde SV, Poser W.
    Arch Intern Med; 2000 Sep 11; 160(16):2548-9. PubMed ID: 10979074
    [No Abstract] [Full Text] [Related]

  • 14. The production of hypericins and hyperforin by in vitro cultures of St. John's wort (Hypericum perforatum).
    Kirakosyan A, Sirvent TM, Gibson DM, Kaufman PB.
    Biotechnol Appl Biochem; 2004 Feb 11; 39(Pt 1):71-81. PubMed ID: 14521510
    [Abstract] [Full Text] [Related]

  • 15. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus B, Schöpf E, Simon JC.
    Br J Dermatol; 2000 May 11; 142(5):979-84. PubMed ID: 10809859
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of hyperforin analogues for inhibition of 5-lipoxygenase.
    Feisst C, Albert D, Verotta L, Werz O.
    Med Chem; 2005 May 11; 1(3):287-91. PubMed ID: 16787324
    [Abstract] [Full Text] [Related]

  • 17. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV, Bhattacharya SK, Ghosal S.
    Indian J Exp Biol; 2001 Dec 11; 39(12):1302-4. PubMed ID: 12018529
    [Abstract] [Full Text] [Related]

  • 18. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.
    J Pharm Pharmacol; 2019 Jan 11; 71(1):129-138. PubMed ID: 29411879
    [Abstract] [Full Text] [Related]

  • 19. A simple and reliable semipreparative high-performance liquid chromatography technique for the isolation of marker-grade hyperforin from Hypericum perforatum L extract.
    Anand R, Puri SC, Verma N, Handa G, Khajuria RK, Gupta VK, Suri OP, Qazi GN.
    J Chromatogr Sci; 2003 Sep 11; 41(8):444-6. PubMed ID: 14558939
    [Abstract] [Full Text] [Related]

  • 20. Structural investigations of isomeric oxidised forms of hyperforin by HPLC-NMR and HPLC-MSn.
    Wolfender JL, Verotta L, Belvisi L, Fuzzati N, Hostettmann K.
    Phytochem Anal; 2003 Sep 11; 14(5):290-7. PubMed ID: 14516001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.